L-octanoylcarnitine

L-octanoylcarnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 311 references associated with L-octanoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for L-octanoylcarnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with L-octanoylcarnitine

MeSH term MeSH ID Detail
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Metabolic Diseases D008659 12 associated lipids
Starvation D013217 47 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Insulin Resistance D007333 99 associated lipids
Thinness D013851 11 associated lipids
Heart Failure, Systolic D054143 3 associated lipids
Total 7

PubChem Associated disorders and diseases

All references with L-octanoylcarnitine

Download all related citations
Per page 10 20 50 100 | Total 70
Authors Title Published Journal PubMed Link
Millington DS et al. Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry. 1985 Clin. Chim. Acta pmid:3919970
Roe CR et al. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. 1986 J. Pediatr. pmid:3944676
Roe CR et al. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency. 1985 Pediatr. Res. pmid:4000772
Duran M et al. Octanoylglucuronide excretion in patients with a defective oxidation of medium-chain fatty acids. 1985 Clin. Chim. Acta pmid:4064333
Chalmers RA et al. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. 1984 Pediatr. Res. pmid:6441143
Kim CS et al. L-carnitine: therapeutic strategy for metabolic encephalopathy. 1984 Brain Res. pmid:6478235
Nakatani T et al. Effects of (+)-octanoylcarnitine on deoxyribonucleic acid synthesis in regenerating rabbit liver. 1982 Clin. Sci. pmid:7060336
Nakatani T et al. Changes in predominant energy substrate after hepatectomy. 1981 Life Sci. pmid:7219046
Parameswaran M and Arinze IJ Phosphoenolpyruvate synthesis by fetal guinea-pig liver mitochondria. 1981 Biochim. Biophys. Acta pmid:7225415
Nakatani T et al. Differences in predominant energy substrate in relation to the resected hepatic mass in the phase immediately after hepatectomy. 1981 J. Lab. Clin. Med. pmid:7229515

Table of Content